Search The Medical Knowledge Base
Medical News by Date
- FDA to review Xgeva(Amgen) potential to delay bone metastases in non-metastatic Prostate Cancer
Published: Friday 30 December 2011
- Xareto (J&J/Bayer) is FDA filed for Acute Coronary Syndrome
Published: Friday 30 December 2011
- Ocriplasmin (Thrombogenics) filed at FDA for Vitreomacular Adhesion.
Published: Thursday 29 December 2011
- FDA approves Single-Site Instrumentation for Da Vinci Si Surgical System (Intuitive Surgical)
Published: Thursday 29 December 2011
- EU approval is given for intravenous formulation of Remodulin (United Therapeutics)
Published: Thursday 29 December 2011
- Flutiform (Skye/Mundipharma) European application referred to arbitration
Published: Wednesday 28 December 2011
- Eisai re-submits perampanel to FDA for Epilepsy
Published: Wednesday 28 December 2011
- FDA to review tofacitinib(Pfizer) for Rheumatoid Arthritis in August 2012
Published: Thursday 22 December 2011
- Tekturna (Novartis) fails ALTITUDE study in Diabetic Hypertensive patients with Renal Impairment
Published: Wednesday 21 December 2011
- CHMP recommends Vepacel (Baxter) Influenza vaccine
Published: Tuesday 20 December 2011
- CHMP recommends Procoralan (Servier Labs) for Chronic Heart Failure
Published: Tuesday 20 December 2011
- European decentralised approval concluded for Steovess (Takeda) for Osteoporosis
Published: Tuesday 20 December 2011
- Olaparib (AstraZeneca)will not proceed to Phase III in Ovarian Cancer
Published: Tuesday 20 December 2011
- TC 5214 fails second Phase III trial for Major Depressive Disorder
Published: Tuesday 20 December 2011
- Aubagio (Sanofi/Genzyme) results in TENERE trial for Multiple Sclerosis
Published: Tuesday 20 December 2011
- FDA updates label safety warning for Multaq (Sanofi-Aventis)
Published: Tuesday 20 December 2011
- Phase III study of Menerba (Bionovo Inc)commences for Menopausal Hot Flashes
Published: Tuesday 20 December 2011
- Truvada filed at FDA for reduction in HIV Risk
Published: Tuesday 20 December 2011
- Pfizer will not proceed with Lyrica for Restless Legs Syndrome
Published: Tuesday 20 December 2011
- CHMP recommends Esmya (PregLem) for pre-operative treatment of Uterine Fibroids
Published: Monday 19 December 2011
- Lamictal (Glaxo Smith Kline) one of superior drug combination for treating Epilepsy
Published: Monday 19 December 2011
- FDA Approves 's Cervista HTA System (Hologic) for Cervical Cancer screening
Published: Monday 19 December 2011
- FDA approves Opana ER from Endo Pharma for Moderate to Severe Pain
Published: Saturday 17 December 2011
- Avastin (Roche/Genentech) prevents spread of Nasopharyngeal Carcinoma in Phase II trial
Published: Saturday 17 December 2011
- FDA approves EXCOR Pediatric System (Berlin Heart) to support Heart Failure patients until a donor is found
Published: Saturday 17 December 2011
- LibiGel (BioSante Pharma) fails two Phase III trials for Female Sexual Dysfunction
Published: Friday 16 December 2011
- NICE recommends RoActemra(Roche) for Systemic Idiopathic Juvenile Arthritis
Published: Friday 16 December 2011
- FDA approves Advate (Baxter) for prophylaxis of Hemophilia A
Published: Friday 16 December 2011
- Zolinza(Merck Inc.) success in Multiple Myeloma trial
Published: Friday 16 December 2011
- Gilenya (Novartis) shows reduction in relapse rates in Phase III Multiple Sclerosis study 2309
Published: Thursday 15 December 2011
- Zolinza (Merck) shows good response with AML patients
Published: Thursday 15 December 2011
- Exjade (Novartis) success in Thalessaemia trial
Published: Thursday 15 December 2011
- Kalydeco is filed at FDA and EMA for Cystic Fibrosis
Published: Thursday 15 December 2011
- ENEST studies of Tasgina (Novartis)show superiority to Glivec in PH+CML
Published: Wednesday 14 December 2011
- BI-201335 (Boehringer Ingelheim) Phase III trial completes recruitment
Published: Wednesday 14 December 2011
- Patients with Chronic Hepatitis C may benefit from Victrelis (Merck) but extent unclear
Published: Wednesday 14 December 2011
- Eyebrain Tracker (EyeBrain) used in Parkinson's Therapy trial
Published: Wednesday 14 December 2011
- Olesoxime(Trophos S.A.) fails Phase III trial for ALS
Published: Wednesday 14 December 2011
- Dificlir (Astellas/Optimer Pharma) is EU approved for Clostridium difficile
Published: Tuesday 13 December 2011
- FDA Advisory committee recommends Adasuve (Aexza Pharma)l for agitation with Sschizophrenia
Published: Tuesday 13 December 2011
- Buccolam(Viro Pharma) is launched in UK for prolonged, acute convulsive seizures in paediatric patients
Published: Tuesday 13 December 2011
- Herceptin (Roche) may equalise DFS for obese and normal weight Breast Cancer patients
Published: Tuesday 13 December 2011
- Omnitarg (Genentech/Roche ) success in CLEOPATRA trial in untreated HER-2 positive Breast Cancer
Published: Monday 12 December 2011
- Why women with Breast Cancer quit aromatase therapy
Published: Monday 12 December 2011
- BTG licence of rights to Voraxaze for Methotrexate Toxicity
Published: Monday 12 December 2011
- Lipitor (Pfizer) may benefit Alzheimer's patients
Published: Sunday 11 December 2011
- Zometa (Novartis) shows clear benefits for premenopausal ER-Positive Breast Cancer patients
Published: Sunday 11 December 2011
- Aromasin (Pfizer) found to lower 'good' cholesterol levels in Breast Cancer patients
Published: Sunday 11 December 2011
- Onduarp (Boehringer) is EMA approved for Essential Hypertension
Published: Saturday 10 December 2011
- Zometa (Novartis) with endocrine therapy improves survival in post menopausal Breast Cancer patients
Published: Saturday 10 December 2011
- FDA advisers vote in favour of Hematide (Takeda/Affymax) approval for Anaemia
Published: Friday 09 December 2011
- NVC-422 (NovaBay) shows potential against adenoviral Conjuctivitis
Published: Friday 09 December 2011
- EU approves Edarbi (Takeda) for Hypertension
Published: Friday 09 December 2011
- Tyverb (GSK) disappoints in HER2 positive Breast Cancer
Published: Friday 09 December 2011
- FDA review of Yaz/Yasmin (Bayer) risk benefit
Published: Friday 09 December 2011
- Addition of Avastin (Genentech) to conventional therapy improves survival in HER2-positive Breast Cancer
Published: Friday 09 December 2011
- Exemestane plus Afinitor (Novartis) increased progression-free survival for Breast Cancer patients
Published: Friday 09 December 2011
- Brachytherapy associated with twofold increased risk for Mastectomy
Published: Friday 09 December 2011
- FDA Advisory Committee recommends Inlyta (Pfizer) for Renal Cell Carcinoma
Published: Thursday 08 December 2011
- Omnitarg (Genentech/Roche) success in Phase II Breast Cancer trial in combination with Herceptin and chemotherapy
Published: Thursday 08 December 2011
- Meta Analysis supports no increased risk of cancer by use of Lantus (Sanofi-Aventis)
Published: Thursday 08 December 2011
- Insulin Degludec plus Insulin Aspart (Novo Nordisk) in Phase III Diabetes trials
Published: Thursday 08 December 2011
- Toviaz(Pfizer) success in Overactive Bladder in Older Patients
Published: Wednesday 07 December 2011
- FDA extends review date of Uplyso (Pfizer)for Gauchers Disease until 1 May 2012
Published: Wednesday 07 December 2011
- Pixuvri (CellTherapeutics) is refiled at the FDA for NHL
Published: Wednesday 07 December 2011
- Generic Caduet (Pfizer) launched in USA by Ranbaxy
Published: Wednesday 07 December 2011
- Cobicistat (Gilead Sciences) success in Study 114 as "booster" in AIDS treatment
Published: Wednesday 07 December 2011
- Lyxumia(Sanofi-Aventis) positive in
GET-GOAL DUO study in Type 2 Diabetes
Published: Wednesday 07 December 2011
- FDA assesses evidence for risk of Thrombosis with drospirenone-containing drugs
Published: Wednesday 07 December 2011
- Daclatasvir (BMS) and TME 435(Tibotec) combination for Phase II for Hepatitis C
Published: Monday 05 December 2011
- Cobas EGFR Mutation test (Roche) receives CE mark for NSCLC testing
Published: Saturday 03 December 2011
- NICE does not recommend Gilenya(Novartis) for Relapsing Remitting Multiple Sclerosis
Published: Thursday 01 December 2011